Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur Arch Otorhinolaryngol ; 273(4): 933-8, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26100031

RESUMEN

The aim of this study was to evaluate the histopathological impact, effectiveness, and safety of two hemostatic agents, Ankaferd Blood Stopper (ABS) and microporous polysaccharide hemospheres (MPH), in an experimental rabbit epistaxis model. Rabbits were randomly assigned, using a computerized random number generator, to the following three groups of six animals: group 1 (control, irrigated with saline); group 2 (ABS-treated); and group 3 (MPH-treated). In all groups, a standardized rabbit epistaxis model was used. Hemostasis time and extent of nasal bleeding were measured to compare the hemostatic effect of ABS and MPH among groups. Septums were removed for histopathological analysis, 7 days after the procedure. ABS reduced hemostasis time to 104.2 s and amount of bleeding to 20.5 mg. MPH reduced hemostasis time to 71.7 s and amount of bleeding to 11.5 mg. Mean bleeding time in wounds administered ABS and MPH was significantly shorter compared with wounds administered isotonic saline solution (p = 0.004). ABS and MPH application decreased bleeding significantly compared with the control group (p = 0.004). Bleeding time and amount in the MPH group was significantly reduced compared with the ABS group (p = 0.013 and p = 0.004, respectively). There was no significant difference in the histopathological evaluation results between the ABS, MPH, and control groups. Our data indicate that both ABS and MPH represent safe, effective, and fast-acting hemostatic agents in the management of epistaxis. MPH was more effective than ABS in terms of hemostasis time and amount of bleeding.


Asunto(s)
Epistaxis , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Administración Tópica , Animales , Tiempo de Sangría/métodos , Modelos Animales de Enfermedad , Epistaxis/diagnóstico , Epistaxis/tratamiento farmacológico , Hemostáticos/farmacología , Conejos , Resultado del Tratamiento
2.
J Photochem Photobiol B ; 149: 289-91, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26123190

RESUMEN

Allergic rhinitis is one of the most common health problems and has a major effect on quality of life. Although new-generation antihistamines and nasal steroids are the main treatment options, complete resolution cannot be obtained in some patients. Besides common side effects such as nasal irritation and epistaxis, the use of these drugs is controversial in some patients, such as pregnant or breastfeeding women. These findings highlight the need for new treatment options. Although phototherapy has been successfully used in the treatment of atopic dermatitis, which is an IgE-mediated disease and shares several common pathogenic features with allergic rhinitis, there are limited studies about its role in the treatment of allergic rhinitis. In this study, we aimed to evaluate and compare the histopathological effects of intranasal phototherapy (Rhinolight) and nasal corticosteroid treatment on the nasal mucosa in allergic rhinitis in a rabbit model and we found that both treatment options significantly reduced inflammation in the nasal mucosa without increasing apoptosis of mucosal cells.


Asunto(s)
Corticoesteroides/farmacología , Mucosa Nasal/efectos de los fármacos , Mucosa Nasal/efectos de la radiación , Fototerapia , Rinitis Alérgica/patología , Rinitis Alérgica/terapia , Administración Intranasal , Corticoesteroides/administración & dosificación , Corticoesteroides/uso terapéutico , Animales , Modelos Animales de Enfermedad , Masculino , Mucosa Nasal/patología , Conejos , Rinitis Alérgica/tratamiento farmacológico
3.
Turk J Med Sci ; 44(3): 381-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25558637

RESUMEN

AIM: To evaluate the effects of montelukast and Hypericum perforatum against ischemia/reperfusion (I/R)-induced intestinal damage. MATERIALS AND METHODS: Twenty-eight hamsters were divided into 4 groups following midline abdominal laparotomy: control group (n = 7), I/R group (n = 7), montelukast and I/R (MIR) group (n = 7), and Hypericum perforatum and I/R (HPIR) group (n = 7). After 60 min of ischemia through obstruction of the superior mesenteric artery, 24 h of reperfusion was maintained. Ten minutes prior to the reperfusion period, the MIR group received 7 mg/kg of intraperitoneal montelukast and the HPIR group received 7 mg/kg of intraperitoneal Hypericum perforatum. Malondialdehyde, glutathione, myeloperoxidase, and cardiotrophin-1 levels were measured from blood samples. A semiquantitative histological evaluation was performed. RESULTS: Montelukast and Hypericum perforatum significantly reduced malondialdehyde levels and increased glutathione levels compared to the I/R group (P < 0.008). A statistically significant difference was also found between the I/R group and MIR and HPIR groups in terms of myelqperoxidase levels (P < 0.008). The MIR and HPIR groups showed increased cardiotrophin- 1 levels compared to the control and I/R groups (P < 0.008 for all). The MIR and HPIR groups showed significantly lower histological scores compared to the I/R group (P = 0.03 and P = 0.007, respectively). CONCLUSION: This study demonstrated the preventive effects of montelukast and Hypericum perforatum on I/R-induced intestinal injury.


Asunto(s)
Acetatos/farmacología , Hypericum/química , Intestinos/irrigación sanguínea , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Quinolinas/farmacología , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/prevención & control , Animales , Cricetinae , Ciclopropanos , Modelos Animales de Enfermedad , Glutatión/sangre , Intestinos/efectos de los fármacos , Malondialdehído/sangre , Arteria Mesentérica Superior/lesiones , Mesocricetus , Distribución Aleatoria , Daño por Reperfusión/sangre , Sulfuros
4.
J Photochem Photobiol B ; 105(1): 94-7, 2011 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-21890373

RESUMEN

Allergic rhinitis is a high-incidence allergic inflammation of the nasal airways that impacts quality of life. Of the numerous therapies used to treat allergic rhinitis, intranasal phototherapy has emerged as a promising new treatment modality for inflammatory airway disease. Phototherapy is widely used for the treatment of immune-mediated skin diseases because its profound immunosuppressive effect inhibits hypersensitivity reactions in the skin. Intranasal phototherapy using a combination of Ultraviolet-A (UVA) and Ultraviolet-B (UVB) plus Visible light (VIS) has been shown to suppress the clinical symptoms of allergic rhinitis, but limited data regarding its adverse effects on the nasal mucosa currently exists. In this study, we demonstrate that UV displays no harmful effects on the nasal mucosa cells of rabbits following 2 weeks of intranasal phototherapy.


Asunto(s)
Mucosa Nasal/patología , Animales , Femenino , Luz , Fototerapia , Conejos , Rinitis/patología , Rinitis/terapia , Rayos Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA